DEXTROMETHORPHAN HYDROBROMIDE

DEXTROMETHORPHAN HYDROBROMIDE was reported 20696 times

DEXTROMETHORPHAN HYDROBROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CRANIAL NERVE DECOMPRESSION 2 0.1111
1 BASILAR ARTERY ANEURYSM 2 0.0606
2 RETENTION CYST 3 0.0588
3 LUNG ADENOCARCINOMA STAGE II 2 0.0588
4 BORRELIA TEST POSITIVE 3 0.0500
5 EYELID MYOCLONUS 3 0.0300
6 DELIRIUM FEBRILE 3 0.0288
7 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA 2 0.0282
8 POST-TRAUMATIC EPILEPSY 2 0.0270
9 HAMARTOMA 2 0.0263
10 CELLULITE 8 0.0245
11 LUMBOSACRAL PLEXOPATHY 2 0.0233
12 PULMONARY HILUM MASS 4 0.0213
13 PROTHROMBIN LEVEL ABNORMAL 3 0.0195
14 NEW ONSET REFRACTORY STATUS EPILEPTICUS 2 0.0182
15 SUDDEN INFANT DEATH SYNDROME 8 0.0163
16 DEEP VEIN THROMBOSIS POSTOPERATIVE 32 0.0160
17 FACET JOINT SYNDROME 48 0.0147
18 CONJUNCTIVAL ULCER 2 0.0145
19 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 2 0.0141
20 IIIRD NERVE DISORDER 2 0.0141
21 MEDIASTINITIS 8 0.0138
22 POSTMORTEM BLOOD DRUG LEVEL INCREASED 5 0.0134
23 GRIP STRENGTH 3 0.0131
24 CAROTID ARTERY ANEURYSM 4 0.0117
25 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 3 0.0116
26 PYELONEPHRITIS CHRONIC 2 0.0106
27 ALVEOLAR LUNG DISEASE 2 0.0105
28 SWOLLEN JOINT COUNT INCREASED 32 0.0100
29 MULTIPLE DRUG OVERDOSE ACCIDENTAL 4 0.0088
30 NECROSIS ISCHAEMIC 4 0.0087
31 C-REACTIVE PROTEIN 8 0.0086
32 RHEUMATIC FEVER 38 0.0085
33 CARCINOID TUMOUR PULMONARY 2 0.0083
34 ANOXIC ENCEPHALOPATHY 5 0.0078
35 CHILD ABUSE 2 0.0077
36 HALLUCINATION, OLFACTORY 3 0.0069
37 C-REACTIVE PROTEIN ABNORMAL 44 0.0069
38 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 14 0.0068
39 UPPER RESPIRATORY TRACT INFLAMMATION 8 0.0067
40 ALLERGY TEST POSITIVE 3 0.0066
41 RHEUMATOID FACTOR POSITIVE 38 0.0066
42 CAUSTIC INJURY 2 0.0064
43 PERIPHERAL ARTERY STENOSIS 3 0.0063
44 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
45 PNEUMONITIS ASPIRATION 2 0.0058
46 CYTOKINE STORM 4 0.0058
47 DRUG TOXICITY 79 0.0058
48 DUODENAL ULCER PERFORATION 43 0.0058
49 FIBROUS HISTIOCYTOMA 2 0.0057
50 PERIPHERAL VENOUS DISEASE 23 0.0056
51 LUPUS VULGARIS 7 0.0056
52 ACCIDENTAL DEATH 10 0.0054
53 IMMUNE THROMBOCYTOPENIA 24 0.0052
54 TOXICOLOGIC TEST ABNORMAL 3 0.0050
55 VASOCONSTRICTION 4 0.0046
56 ACCIDENTAL DRUG INTAKE BY CHILD 7 0.0046
57 HANGOVER 16 0.0045
58 MATERNAL EXPOSURE TIMING UNSPECIFIED 17 0.0045
59 DELUSION OF GRANDEUR 2 0.0045
60 LIP DRY 40 0.0044
61 FEELING OF RELAXATION 3 0.0044
62 PUPILLARY REFLEX IMPAIRED 8 0.0043
63 FOLLICULITIS 45 0.0043
64 NEUTROPHIL COUNT ABNORMAL 12 0.0042
65 OPIATES POSITIVE 2 0.0042
66 DISSOCIATIVE DISORDER 3 0.0042
67 SEROTONIN SYNDROME 79 0.0041
68 AMNESTIC DISORDER 2 0.0041
69 CEREBRAL ARTERY STENOSIS 2 0.0041
70 RETINITIS 7 0.0040
71 HELICOBACTER INFECTION 41 0.0040
72 DISLOCATION OF VERTEBRA 9 0.0039
73 SQUAMOUS CELL CARCINOMA OF LUNG 3 0.0039
74 BREAST CONSERVING SURGERY 2 0.0039
75 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 25 0.0038
76 MEASLES 2 0.0037
77 PNEUMONIA STREPTOCOCCAL 4 0.0036
78 JOINT ANKYLOSIS 2 0.0035
79 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 25 0.0035
80 AUTOIMMUNE DISORDER 34 0.0035
81 ENANTHEMA 2 0.0035
82 PNEUMONIA INFLUENZAL 4 0.0034
83 X-RAY ABNORMAL 6 0.0034
84 LIVE BIRTH 28 0.0033
85 DRUG ABUSE 273 0.0033
86 PEMPHIGUS 40 0.0032
87 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
88 ANION GAP 2 0.0032
89 POLYSUBSTANCE ABUSE 2 0.0031
90 HYPERCHLORAEMIA 2 0.0031
91 SPUTUM RETENTION 3 0.0030
92 MULTIPLE DRUG OVERDOSE 15 0.0030
93 ORAL MUCOSAL DISCOLOURATION 2 0.0030
94 PARADOXICAL DRUG REACTION 11 0.0030
95 SLOW SPEECH 7 0.0029
96 LYMPHANGIOSIS CARCINOMATOSA 3 0.0029
97 ELECTROENCEPHALOGRAM ABNORMAL 9 0.0028
98 HAND DEFORMITY 37 0.0028
99 PORPHYRIA ACUTE 4 0.0028
100 MUSCLE INJURY 23 0.0028
101 VITAMIN B12 DECREASED 8 0.0028
102 JOINT RANGE OF MOTION DECREASED 37 0.0028
103 IMMUNE-MEDIATED LUNG DISEASE 5 0.0027
104 BURSITIS 32 0.0026
105 RESPIRATORY ARREST 72 0.0026
106 HYPERREFLEXIA 9 0.0026
107 CLONUS 7 0.0026
108 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 5 0.0025
109 HERPES ZOSTER DISSEMINATED 2 0.0025
110 NYSTAGMUS 13 0.0024
111 MYDRIASIS 31 0.0024
112 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 3 0.0024
113 RADIATION PNEUMONITIS 5 0.0023
114 BRONCHOPNEUMONIA 8 0.0023
115 SUBSTANCE ABUSE 19 0.0023
116 AORTIC ARTERIOSCLEROSIS 6 0.0023
117 OESOPHAGEAL VARICES HAEMORRHAGE 5 0.0023
118 HYPERLEUKOCYTOSIS 2 0.0023
119 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 2 0.0022
120 ALCOHOL POISONING 6 0.0022
121 EOSINOPHILIC PNEUMONIA 7 0.0022
122 CONDUCTION DISORDER 4 0.0022
123 HEAD TITUBATION 3 0.0022
124 HAEMOGLOBIN ABNORMAL 14 0.0022
125 COMPLETED SUICIDE 179 0.0021
126 PERICARDITIS 36 0.0021
127 BUNDLE BRANCH BLOCK 2 0.0021
128 DRUG ABUSER 13 0.0021
129 FIBROMYALGIA 51 0.0021
130 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
131 PNEUMONIA BACTERIAL 19 0.0021
132 CONVERSION DISORDER 4 0.0021
133 IMMUNE-MEDIATED HEPATIC DISORDER 4 0.0020
134 SLEEP PARALYSIS 3 0.0020
135 ENTEROCOLITIS HAEMORRHAGIC 3 0.0020
136 IMMUNE-MEDIATED DERMATITIS 2 0.0020
137 SCIATICA 31 0.0019
138 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
139 LUNG ABSCESS 4 0.0019
140 WHITE BLOOD CELL COUNT ABNORMAL 12 0.0019
141 IMMUNE-MEDIATED MYOCARDITIS 3 0.0019
142 LANGUAGE DISORDER 4 0.0018
143 LIVER INJURY 45 0.0018
144 GLOSSODYNIA 41 0.0018
145 SYNOVITIS 33 0.0018
146 IRRITABLE BOWEL SYNDROME 39 0.0018
147 RETROPERITONEAL HAEMATOMA 4 0.0018
148 MALIGNANT PLEURAL EFFUSION 3 0.0018
149 DIFFUSE ALVEOLAR DAMAGE 2 0.0017
150 LUNG CANCER METASTATIC 5 0.0017
151 FOLATE DEFICIENCY 2 0.0017
152 PUPIL FIXED 3 0.0017
153 FLAT AFFECT 4 0.0017
154 INTENTIONAL DRUG MISUSE 36 0.0017
155 EXTREMITY NECROSIS 3 0.0017
156 HAEMATOMA MUSCLE 2 0.0017
157 FEBRILE CONVULSION 2 0.0016
158 HAEMATOCRIT ABNORMAL 2 0.0016
159 RESPIRATORY RATE DECREASED 5 0.0016
160 TOXIC ENCEPHALOPATHY 8 0.0016
161 MULTIPLE DRUG OVERDOSE INTENTIONAL 5 0.0016
162 PLATELET TRANSFUSION 2 0.0016
163 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
164 DRUG LEVEL ABOVE THERAPEUTIC 7 0.0015
165 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
166 POISONING 19 0.0015
167 LOWER LIMB FRACTURE 29 0.0015
168 LIP EXFOLIATION 2 0.0015
169 COLITIS ISCHAEMIC 10 0.0015
170 ULCER HAEMORRHAGE 10 0.0015
171 ACCIDENTAL POISONING 2 0.0015
172 CARDIO-RESPIRATORY ARREST 61 0.0015
173 OBESITY 23 0.0014
174 PULMONARY CONGESTION 19 0.0014
175 ATRIAL TACHYCARDIA 3 0.0014
176 DRUG TOLERANCE DECREASED 4 0.0014
177 HEPATIC NEOPLASM MALIGNANT 3 0.0014
178 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
179 BONE EROSION 5 0.0014
180 TOXICITY TO VARIOUS AGENTS 237 0.0014
181 INTERSTITIAL LUNG DISEASE 68 0.0014
182 DRUG SCREEN POSITIVE 11 0.0014
183 OESOPHAGITIS 15 0.0014
184 LIVER DISORDER 60 0.0014
185 PNEUMONIA PNEUMOCOCCAL 2 0.0013
186 DISSEMINATED INTRAVASCULAR COAGULATION 19 0.0013
187 HEPATITIS FULMINANT 4 0.0013
188 INTENTIONAL OVERDOSE 86 0.0013
189 HYPERCAPNIA 4 0.0013
190 INFECTIOUS PLEURAL EFFUSION 2 0.0013
191 PNEUMONIA PSEUDOMONAL 2 0.0013
192 BRAIN DEATH 4 0.0013
193 ERYTHEMA MULTIFORME 12 0.0013
194 VARICELLA 3 0.0013
195 OXYGEN CONSUMPTION INCREASED 3 0.0013
196 PNEUMONIA VIRAL 4 0.0013
197 NON-SMALL CELL LUNG CANCER 6 0.0013
198 WRONG DRUG ADMINISTERED 11 0.0012
199 CRYPTOCOCCOSIS 2 0.0012
200 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
201 PARANOIA 21 0.0012
202 TYPE 2 DIABETES MELLITUS 41 0.0012
203 ACUTE PSYCHOSIS 3 0.0012
204 EXPOSURE DURING PREGNANCY 75 0.0012
205 ACCIDENTAL OVERDOSE 44 0.0012
206 DERMATITIS EXFOLIATIVE 6 0.0012
207 WOUND 33 0.0012
208 GAZE PALSY 2 0.0012
209 EUPHORIC MOOD 12 0.0012
210 PULMONARY TUBERCULOSIS 5 0.0012
211 BLOOD PH DECREASED 2 0.0012
212 IMPAIRED HEALING 38 0.0012
213 HYPOPITUITARISM 2 0.0011
214 ROAD TRAFFIC ACCIDENT 48 0.0011
215 OTORRHOEA 2 0.0011
216 LUNG OPACITY 3 0.0011
217 PSORIATIC ARTHROPATHY 46 0.0011
218 RESPIRATORY RATE INCREASED 10 0.0011
219 NASAL DRYNESS 7 0.0011
220 BLOOD SODIUM INCREASED 3 0.0011
221 PNEUMOMEDIASTINUM 2 0.0011
222 MUSCLE RIGIDITY 13 0.0011
223 DRUG SCREEN FALSE POSITIVE 3 0.0011
224 BREAST CANCER STAGE III 7 0.0011
225 BRADYPHRENIA 7 0.0011
226 HYPERTENSIVE HEART DISEASE 2 0.0011
227 HEPATIC MASS 2 0.0010
228 ABDOMINAL WALL HAEMATOMA 2 0.0010
229 PSYCHIATRIC DECOMPENSATION 2 0.0010
230 GRIP STRENGTH DECREASED 9 0.0010
231 GAIT INABILITY 34 0.0010
232 SYSTEMIC LUPUS ERYTHEMATOSUS 36 0.0010
233 OEDEMA 55 0.0010
234 PLEURISY 6 0.0010
235 CELL DEATH 2 0.0010
236 EMPYEMA 2 0.0010
237 WOUND INFECTION 11 0.0010
238 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
239 PULMONARY TOXICITY 7 0.0010
240 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
241 REBOUND EFFECT 11 0.0010
242 ACCIDENTAL EXPOSURE 4 0.0010
243 DELIRIUM 33 0.0009
244 CAESAREAN SECTION 11 0.0009
245 HYPERKINESIA 2 0.0009
246 PULMONARY FIBROSIS 18 0.0009
247 HYPERCHOLESTEROLAEMIA 9 0.0009
248 DEREALISATION 2 0.0009
249 HENOCH-SCHONLEIN PURPURA 2 0.0009
250 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
251 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
252 THERAPY NON-RESPONDER 41 0.0009
253 INJURY 64 0.0009
254 WALKING AID USER 6 0.0009
255 CARDIAC ARREST 75 0.0009
256 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
257 POTENTIATING DRUG INTERACTION 3 0.0009
258 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
259 IRON DEFICIENCY 4 0.0009
260 HEPATIC FUNCTION ABNORMAL 33 0.0009
261 METASTASES TO MENINGES 2 0.0009
262 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
263 PERIARTHRITIS 2 0.0009
264 PRESCRIBED OVERDOSE 17 0.0009
265 INTENTIONAL PRODUCT MISUSE 76 0.0009
266 PERFORMANCE STATUS DECREASED 4 0.0009
267 THROMBOPHLEBITIS 3 0.0009
268 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
269 FIBRIN D DIMER INCREASED 3 0.0008
270 CONJUNCTIVAL HYPERAEMIA 3 0.0008
271 SLEEP DISORDER 59 0.0008
272 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
273 RESPIRATORY DEPRESSION 10 0.0008
274 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
275 ORGANISING PNEUMONIA 4 0.0008
276 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
277 PREGNANCY 16 0.0008
278 INFLAMMATION 41 0.0008
279 BLEPHAROSPASM 5 0.0008
280 OSTEITIS 2 0.0008
281 DRUG ERUPTION 14 0.0008
282 DERMATOMYOSITIS 2 0.0008
283 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
284 HYPERTHERMIA 6 0.0008
285 INFUSION RELATED REACTION 52 0.0008
286 ANGLE CLOSURE GLAUCOMA 2 0.0008
287 CANCER PAIN 2 0.0008
288 INCREASED BRONCHIAL SECRETION 2 0.0008
289 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
290 PHYSICAL DECONDITIONING 2 0.0008
291 SINUS TACHYCARDIA 11 0.0008
292 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
293 LIPOMA 2 0.0008
294 STOMATITIS 46 0.0008
295 PNEUMOTHORAX 12 0.0008
296 SUDDEN DEATH 8 0.0008
297 LUNG DISORDER 37 0.0008
298 MYOCLONUS 9 0.0008
299 MOBILITY DECREASED 54 0.0008
300 OBSTRUCTION 3 0.0008
301 SHOCK HAEMORRHAGIC 6 0.0007
302 CLUMSINESS 2 0.0007
303 BLOOD CHOLESTEROL INCREASED 34 0.0007
304 WHEEZING 43 0.0007
305 PNEUMONIA ASPIRATION 18 0.0007
306 PROCTITIS 2 0.0007
307 NIGHT SWEATS 23 0.0007
308 DRUG USE DISORDER 6 0.0007
309 HALLUCINATIONS, MIXED 3 0.0007
310 PSYCHOMOTOR RETARDATION 2 0.0007
311 DRY MOUTH 57 0.0007
312 BRONCHOSPASM 10 0.0007
313 UNRESPONSIVE TO STIMULI 18 0.0007
314 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
315 COMA 33 0.0007
316 SUICIDE ATTEMPT 42 0.0007
317 STRESS CARDIOMYOPATHY 4 0.0007
318 GASTROINTESTINAL NECROSIS 2 0.0007
319 ILL-DEFINED DISORDER 41 0.0007
320 ATAXIA 8 0.0007
321 INFUSION SITE REACTION 2 0.0007
322 DRUG-INDUCED LIVER INJURY 21 0.0007
323 LUNG ADENOCARCINOMA 2 0.0007
324 TYPE 1 DIABETES MELLITUS 4 0.0007
325 CEREBROVASCULAR DISORDER 2 0.0007
326 EYE INJURY 2 0.0007
327 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
328 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
329 TROPONIN INCREASED 5 0.0007
330 EXOSTOSIS 6 0.0007
331 DYSCHEZIA 2 0.0007
332 LIPASE INCREASED 5 0.0007
333 SHOCK 15 0.0007
334 ARTHROPATHY 36 0.0006
335 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
336 BILE DUCT STONE 2 0.0006
337 INCOHERENT 4 0.0006
338 HEPATIC ENZYME INCREASED 42 0.0006
339 HYPOVENTILATION 2 0.0006
340 ORAL CANDIDIASIS 8 0.0006
341 DRUG LEVEL INCREASED 10 0.0006
342 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
343 LOWER RESPIRATORY TRACT INFECTION 27 0.0006
344 DYSLIPIDAEMIA 3 0.0006
345 DRY THROAT 6 0.0006
346 OSTEOARTHRITIS 25 0.0006
347 SINUSITIS 60 0.0006
348 FEMORAL NECK FRACTURE 3 0.0006
349 HEPATIC FIBROSIS 2 0.0006
350 PUSTULAR PSORIASIS 2 0.0006
351 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
352 HYPERTRANSAMINASAEMIA 4 0.0006
353 DRUG INTERACTION 91 0.0006
354 RIGHT VENTRICULAR FAILURE 4 0.0006
355 EOSINOPHILIA 10 0.0006
356 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
357 JOINT DISLOCATION 6 0.0006
358 FACIAL PARESIS 2 0.0006
359 SEASONAL ALLERGY 8 0.0006
360 ABSCESS 9 0.0006
361 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
362 GLOSSITIS 2 0.0006
363 BEHAVIOUR DISORDER 3 0.0006
364 BRAIN OEDEMA 7 0.0006
365 DERMATITIS BULLOUS 4 0.0006
366 LUPUS-LIKE SYNDROME 5 0.0006
367 FAECES SOFT 4 0.0005
368 CUTANEOUS VASCULITIS 2 0.0005
369 DEAFNESS UNILATERAL 3 0.0005
370 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
371 ANOREXIA 7 0.0005
372 PSYCHOTIC DISORDER 16 0.0005
373 URINARY RETENTION 18 0.0005
374 NECROSIS 3 0.0005
375 MUSCULOSKELETAL PAIN 28 0.0005
376 CHRONIC SINUSITIS 2 0.0005
377 ARTERIOSCLEROSIS 5 0.0005
378 AGITATION 39 0.0005
379 POISONING DELIBERATE 5 0.0005
380 WITHDRAWAL SYNDROME 22 0.0005
381 HYPERTONIA 3 0.0005
382 PRODUCTIVE COUGH 25 0.0005
383 COMMUNICATION DISORDER 2 0.0005
384 VISUAL DISTURBANCE 3 0.0005
385 ASTHMA 59 0.0005
386 DISSOCIATION 4 0.0005
387 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 37 0.0005
388 ENTEROCOLITIS 3 0.0005
389 PRODUCT TASTE ABNORMAL 7 0.0005
390 CONGENITAL ANOMALY 4 0.0005
391 PANIC DISORDER 2 0.0005
392 BLISTER 29 0.0005
393 HYPOALBUMINAEMIA 4 0.0005
394 EPIGASTRIC DISCOMFORT 2 0.0005
395 COVID-19 PNEUMONIA 6 0.0005
396 DISCOMFORT 31 0.0005
397 PNEUMONIA FUNGAL 2 0.0005
398 PREMATURE DELIVERY 8 0.0005
399 HAEMOPTYSIS 14 0.0005
400 COORDINATION ABNORMAL 7 0.0005
401 ATRIAL FLUTTER 4 0.0005
402 PRESCRIBED UNDERDOSE 10 0.0005
403 AGGRESSION 25 0.0005
404 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
405 ORGAN FAILURE 2 0.0005
406 EMPHYSEMA 5 0.0005
407 DERMATITIS ACNEIFORM 3 0.0005
408 ASPHYXIA 4 0.0005
409 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
410 ENCEPHALOPATHY 12 0.0005
411 MUSCLE SPASTICITY 6 0.0005
412 LARYNGEAL OEDEMA 3 0.0005
413 DRUG DIVERSION 3 0.0005
414 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
415 AORTIC DISSECTION 2 0.0005
416 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
417 CYTOMEGALOVIRUS INFECTION 8 0.0005
418 SWELLING 45 0.0005
419 HAEMODIALYSIS 4 0.0005
420 FACE OEDEMA 8 0.0005
421 HALLUCINATION, VISUAL 10 0.0005
422 JOINT SWELLING 57 0.0005
423 CARDIAC FAILURE CHRONIC 2 0.0005
424 RETCHING 10 0.0005
425 LUNG NEOPLASM 2 0.0005
426 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
427 NEUTROPHIL COUNT DECREASED 19 0.0005
428 ANAPHYLACTIC SHOCK 12 0.0005
429 HORDEOLUM 2 0.0005
430 PHARYNGITIS STREPTOCOCCAL 5 0.0005
431 OCULAR ICTERUS 2 0.0005
432 DIVERTICULUM INTESTINAL 2 0.0005
433 HIP ARTHROPLASTY 7 0.0005
434 PARONYCHIA 2 0.0005
435 ABDOMINAL ABSCESS 2 0.0005
436 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
437 FOOT DEFORMITY 5 0.0005
438 DELUSION 7 0.0005
439 MENINGITIS 3 0.0004
440 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
441 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
442 MYOSITIS 4 0.0004
443 SKIN INFECTION 5 0.0004
444 CONFUSIONAL STATE 72 0.0004
445 OROPHARYNGEAL DISCOMFORT 4 0.0004
446 BODY TEMPERATURE INCREASED 9 0.0004
447 EYE MOVEMENT DISORDER 3 0.0004
448 SEPTIC SHOCK 19 0.0004
449 RESPIRATION ABNORMAL 3 0.0004
450 DRUG INTOLERANCE 42 0.0004
451 GENERAL PHYSICAL HEALTH DETERIORATION 50 0.0004
452 AUTOIMMUNE HEPATITIS 3 0.0004
453 HYPOXIA 15 0.0004
454 GASTROINTESTINAL DISORDER 38 0.0004
455 PYREXIA 146 0.0004
456 BACTERAEMIA 5 0.0004
457 PULSE ABSENT 2 0.0004
458 ACUTE RESPIRATORY FAILURE 8 0.0004
459 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
460 INCORRECT DOSAGE ADMINISTERED 2 0.0004
461 OVERDOSE 88 0.0004
462 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
463 METABOLIC ACIDOSIS 13 0.0004
464 CARDIOMEGALY 5 0.0004
465 BREATH SOUNDS ABNORMAL 2 0.0004
466 CONTUSION 39 0.0004
467 STEVENS-JOHNSON SYNDROME 9 0.0004
468 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
469 PLATELET COUNT DECREASED 43 0.0004
470 ABDOMINAL TENDERNESS 2 0.0004
471 PULMONARY OEDEMA 18 0.0004
472 TOOTH EXTRACTION 5 0.0004
473 RESPIRATORY DISORDER 12 0.0004
474 ADVERSE DRUG REACTION 36 0.0004
475 HYPERAMMONAEMIA 2 0.0004
476 RESPIRATORY DISTRESS 11 0.0004
477 DYSARTHRIA 15 0.0004
478 CORONARY ARTERY STENOSIS 2 0.0004
479 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
480 ISCHAEMIC STROKE 7 0.0004
481 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
482 PHLEBITIS 2 0.0004
483 INCREASED UPPER AIRWAY SECRETION 2 0.0004
484 PERIPHERAL VASCULAR DISORDER 2 0.0004
485 INFECTION 56 0.0004
486 LEUKOCYTOSIS 7 0.0004
487 APNOEA 3 0.0004
488 TENDERNESS 4 0.0004
489 PULMONARY HAEMORRHAGE 3 0.0004
490 PETECHIAE 4 0.0004
491 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
492 CYANOSIS 6 0.0004
493 BLOOD LACTIC ACID INCREASED 2 0.0004
494 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
495 FURUNCLE 3 0.0004
496 LOW BIRTH WEIGHT BABY 3 0.0004
497 FOOD POISONING 2 0.0004
498 COMPRESSION FRACTURE 2 0.0004
499 HEPATIC CIRRHOSIS 7 0.0004
500 MYASTHENIA GRAVIS 3 0.0004
501 COUGH 104 0.0004
502 CHEILITIS 2 0.0004
503 HYPERTENSION 78 0.0004
504 ACUTE HEPATIC FAILURE 5 0.0004
505 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
506 BRONCHITIS 27 0.0004
507 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
508 GASTRIC ULCER HAEMORRHAGE 2 0.0004
509 MENTAL STATUS CHANGES 10 0.0004
510 HEPATOTOXICITY 8 0.0004
511 HYPOMAGNESAEMIA 5 0.0004
512 HEART RATE ABNORMAL 2 0.0004
513 URTICARIA 60 0.0004
514 INTERMENSTRUAL BLEEDING 2 0.0004
515 ANGIOPATHY 2 0.0004
516 INSOMNIA 95 0.0004
517 HYPERSENSITIVITY 66 0.0004
518 STATUS EPILEPTICUS 4 0.0004
519 DISABILITY 7 0.0004
520 MITRAL VALVE INCOMPETENCE 4 0.0004
521 GENERALISED ERYTHEMA 2 0.0004
522 NEUROLOGICAL SYMPTOM 2 0.0003
523 PNEUMONIA 113 0.0003
524 BLOOD MAGNESIUM DECREASED 3 0.0003
525 MULTI-ORGAN FAILURE 6 0.0003
526 METASTASES TO LUNG 4 0.0003
527 HYPERVENTILATION 2 0.0003
528 ABDOMINAL PAIN UPPER 71 0.0003
529 ELECTROLYTE IMBALANCE 4 0.0003
530 ANAPHYLACTIC REACTION 19 0.0003
531 WEIGHT INCREASED 77 0.0003
532 URINE OUTPUT DECREASED 3 0.0003
533 GASTRITIS 9 0.0003
534 MEDICATION ERROR 19 0.0003
535 SPINAL OSTEOARTHRITIS 3 0.0003
536 IMMUNOSUPPRESSION 3 0.0003
537 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
538 TACHYCARDIA 30 0.0003
539 RHEUMATOID ARTHRITIS 38 0.0003
540 JAUNDICE 9 0.0003
541 PROTHROMBIN TIME PROLONGED 2 0.0003
542 ANAL INCONTINENCE 3 0.0003
543 HEPATIC FAILURE 10 0.0003
544 LETHARGY 19 0.0003
545 ADRENAL INSUFFICIENCY 4 0.0003
546 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
547 RESTLESSNESS 12 0.0003
548 DECREASED APPETITE 76 0.0003
549 NASOPHARYNGITIS 60 0.0003
550 DEVICE RELATED INFECTION 5 0.0003
551 PRODUCT DISTRIBUTION ISSUE 3 0.0003
552 NASAL CONGESTION 19 0.0003
553 GENERALISED OEDEMA 4 0.0003
554 PERSONALITY CHANGE 3 0.0003
555 CHOLANGITIS 2 0.0003
556 HEPATIC STEATOSIS 6 0.0003
557 ILEUS 4 0.0003
558 HEPATIC ENCEPHALOPATHY 3 0.0003
559 INFUSION SITE EXTRAVASATION 2 0.0003
560 OXYGEN SATURATION DECREASED 18 0.0003
561 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
562 MUSCULOSKELETAL STIFFNESS 28 0.0003
563 HYPONATRAEMIA 18 0.0003
564 CONDITION AGGRAVATED 97 0.0003
565 INFUSION SITE SWELLING 2 0.0003
566 PRODUCT USE COMPLAINT 5 0.0003
567 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
568 GASTRIC ULCER 6 0.0003
569 PROTEINURIA 6 0.0003
570 HALLUCINATION, AUDITORY 5 0.0003
571 RASH MACULO-PAPULAR 7 0.0003
572 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
573 HYPOAESTHESIA 47 0.0003
574 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
575 PLEURAL EFFUSION 19 0.0003
576 OEDEMA PERIPHERAL 38 0.0003
577 RHABDOMYOLYSIS 13 0.0003
578 SINUS BRADYCARDIA 3 0.0003
579 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
580 DIZZINESS POSTURAL 3 0.0003
581 EAR PAIN 6 0.0003
582 BLOOD POTASSIUM INCREASED 5 0.0003
583 VITAMIN D DEFICIENCY 3 0.0003
584 BODY TEMPERATURE DECREASED 3 0.0003
585 LOSS OF CONSCIOUSNESS 39 0.0003
586 IMMUNE SYSTEM DISORDER 4 0.0003
587 SINUS DISORDER 6 0.0003
588 VENTRICULAR TACHYCARDIA 5 0.0003
589 BLOOD PRESSURE DECREASED 20 0.0003
590 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
591 CYTOKINE RELEASE SYNDROME 6 0.0003
592 BLOOD UREA INCREASED 5 0.0003
593 INTENTIONAL SELF-INJURY 6 0.0003
594 HYPOTHERMIA 3 0.0003
595 MOTOR DYSFUNCTION 3 0.0003
596 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
597 PNEUMONITIS 8 0.0003
598 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
599 AMNESIA 19 0.0003
600 NEPHROTIC SYNDROME 2 0.0003
601 THROAT IRRITATION 13 0.0003
602 HYPERHIDROSIS 37 0.0003
603 SEPSIS 32 0.0003
604 HYPERKALAEMIA 10 0.0003
605 KNEE ARTHROPLASTY 6 0.0003
606 PAPULE 2 0.0003
607 ABDOMINAL DISCOMFORT 47 0.0003
608 PRODUCT SUPPLY ISSUE 2 0.0003
609 IMPAIRED QUALITY OF LIFE 4 0.0003
610 ABNORMAL BEHAVIOUR 11 0.0003
611 DISORIENTATION 11 0.0003
612 DIZZINESS 138 0.0003
613 RESTLESS LEGS SYNDROME 5 0.0003
614 DYSPEPSIA 27 0.0003
615 RESPIRATORY FAILURE 20 0.0003
616 COVID-19 48 0.0003
617 MOUTH HAEMORRHAGE 2 0.0003
618 MELAENA 6 0.0003
619 MIGRAINE 26 0.0003
620 EXPIRED PRODUCT ADMINISTERED 9 0.0003
621 VIRAL INFECTION 9 0.0003
622 VENTRICULAR FIBRILLATION 3 0.0003
623 ARTHROPOD BITE 2 0.0003
624 FEELING DRUNK 2 0.0003
625 RESPIRATORY TRACT INFECTION 7 0.0003
626 THINKING ABNORMAL 5 0.0003
627 SEDATION 7 0.0003
628 KETOACIDOSIS 2 0.0003
629 PANCREATITIS ACUTE 6 0.0003
630 GENERAL SYMPTOM 2 0.0003
631 COLITIS 10 0.0003
632 EAR INFECTION 7 0.0003
633 MYOCARDITIS 3 0.0003
634 FEELING HOT 16 0.0003
635 BLOOD CREATININE INCREASED 17 0.0003
636 UNDERDOSE 19 0.0003
637 DISTURBANCE IN ATTENTION 14 0.0003
638 PERICARDIAL EFFUSION 6 0.0003
639 ATRIOVENTRICULAR BLOCK 2 0.0003
640 SOMNOLENCE 52 0.0003
641 VASCULITIS 3 0.0003
642 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
643 LUNG INFECTION 4 0.0003
644 DYSPHONIA 15 0.0003
645 CHOKING 5 0.0003
646 ORAL HERPES 5 0.0003
647 BRAIN FOG 4 0.0003
648 MULTIPLE ALLERGIES 2 0.0003
649 ACUTE KIDNEY INJURY 39 0.0003
650 EPISTAXIS 19 0.0003
651 CHEST PAIN 47 0.0003
652 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
653 RESPIRATORY TRACT CONGESTION 4 0.0003
654 ACCIDENT 3 0.0003
655 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
656 MIOSIS 2 0.0002
657 RHINORRHOEA 16 0.0002
658 C-REACTIVE PROTEIN INCREASED 9 0.0002
659 PRESYNCOPE 6 0.0002
660 NO THERAPEUTIC RESPONSE 3 0.0002
661 DECUBITUS ULCER 2 0.0002
662 ABDOMINAL PAIN 57 0.0002
663 SMALL INTESTINAL OBSTRUCTION 3 0.0002
664 HICCUPS 2 0.0002
665 DIARRHOEA 157 0.0002
666 DYSPNOEA 137 0.0002
667 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
668 LIVER FUNCTION TEST ABNORMAL 7 0.0002
669 SECRETION DISCHARGE 3 0.0002
670 HALLUCINATION 18 0.0002
671 DERMATITIS ALLERGIC 3 0.0002
672 CIRCULATORY COLLAPSE 4 0.0002
673 HEART RATE INCREASED 23 0.0002
674 HIATUS HERNIA 3 0.0002
675 MUSCLE STRAIN 2 0.0002
676 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
677 CONVULSION 13 0.0002
678 CARDIAC FAILURE 18 0.0002
679 VOMITING 105 0.0002
680 GASTROINTESTINAL INFECTION 2 0.0002
681 FREQUENT BOWEL MOVEMENTS 6 0.0002
682 CHROMATURIA 5 0.0002
683 GAIT DISTURBANCE 42 0.0002
684 HYPOTHYROIDISM 7 0.0002
685 PRODUCT USE ISSUE 41 0.0002
686 INCREASED TENDENCY TO BRUISE 2 0.0002
687 TREATMENT FAILURE 18 0.0002
688 MUSCLE TWITCHING 5 0.0002
689 FEELING COLD 6 0.0002
690 BACTERIAL INFECTION 4 0.0002
691 PERIPHERAL SWELLING 33 0.0002
692 APPENDICITIS 2 0.0002
693 ASTHENIA 80 0.0002
694 ABORTION INDUCED 2 0.0002
695 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
696 DRUG INEFFECTIVE 279 0.0002
697 HYPOCALCAEMIA 4 0.0002
698 MUSCULAR WEAKNESS 24 0.0002
699 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
700 SLEEP APNOEA SYNDROME 4 0.0002
701 SUBDURAL HAEMATOMA 3 0.0002
702 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
703 RECTAL HAEMORRHAGE 9 0.0002
704 HYPERSOMNIA 6 0.0002
705 PARAESTHESIA ORAL 3 0.0002
706 MALAISE 91 0.0002
707 BRADYCARDIA 11 0.0002
708 ANOSMIA 3 0.0002
709 HYPERTHYROIDISM 3 0.0002
710 ATELECTASIS 2 0.0002
711 TREMOR 34 0.0002
712 PHARYNGEAL SWELLING 2 0.0002
713 ASCITES 6 0.0002
714 NIGHTMARE 7 0.0002
715 PULMONARY MASS 3 0.0002
716 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
717 AGEUSIA 5 0.0002
718 HYPOTONIA 2 0.0002
719 BLOOD POTASSIUM DECREASED 6 0.0002
720 HYPOTENSION 40 0.0002
721 ANAEMIA 38 0.0002
722 HYPOAESTHESIA ORAL 3 0.0002
723 INFLUENZA 22 0.0002
724 TASTE DISORDER 4 0.0002
725 VERTIGO 12 0.0002
726 INSURANCE ISSUE 3 0.0002
727 HYPOKALAEMIA 9 0.0002
728 INITIAL INSOMNIA 2 0.0002
729 URINARY TRACT INFECTION 33 0.0002
730 ANXIETY 55 0.0002
731 RASH 84 0.0002
732 ACUTE MYELOID LEUKAEMIA 3 0.0002
733 HYPERGLYCAEMIA 7 0.0002
734 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
735 PRODUCT ODOUR ABNORMAL 2 0.0002
736 PARAESTHESIA 30 0.0002
737 JOINT STIFFNESS 5 0.0002
738 FULL BLOOD COUNT ABNORMAL 2 0.0002
739 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
740 DEHYDRATION 25 0.0002
741 LIVER FUNCTION TEST INCREASED 4 0.0002
742 DYSPNOEA EXERTIONAL 7 0.0002
743 FAECES DISCOLOURED 4 0.0002
744 ADVERSE EVENT 17 0.0002
745 TREATMENT NONCOMPLIANCE 10 0.0002
746 ASPIRATION 2 0.0002
747 MANIA 3 0.0002
748 FEBRILE NEUTROPENIA 12 0.0002
749 SKIN DISORDER 6 0.0002
750 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
751 COLITIS ULCERATIVE 8 0.0002
752 RENAL IMPAIRMENT 15 0.0002
753 NEPHROPATHY TOXIC 2 0.0002
754 BLOOD CALCIUM DECREASED 2 0.0002
755 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
756 IMPAIRED DRIVING ABILITY 2 0.0002
757 HAEMATURIA 6 0.0002
758 MICTURITION URGENCY 2 0.0002
759 INTERNAL HAEMORRHAGE 2 0.0002
760 ATRIAL FIBRILLATION 17 0.0002
761 PRURITUS 67 0.0002
762 MUSCULOSKELETAL DISCOMFORT 3 0.0002
763 OROPHARYNGEAL PAIN 16 0.0002
764 POST PROCEDURAL HAEMORRHAGE 2 0.0002
765 NEUROTOXICITY 3 0.0002
766 AMENORRHOEA 3 0.0002
767 METASTASES TO LIVER 3 0.0002
768 OSTEOPOROSIS 7 0.0002
769 LYMPHOCYTE COUNT DECREASED 3 0.0002
770 PRODUCT USE IN UNAPPROVED INDICATION 42 0.0002
771 LABORATORY TEST ABNORMAL 5 0.0002
772 HYPERLIPIDAEMIA 2 0.0002
773 FLUSHING 17 0.0002
774 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
775 DIABETIC KETOACIDOSIS 4 0.0002
776 GASTROENTERITIS VIRAL 3 0.0002
777 PREMATURE BABY 5 0.0002
778 CORONARY ARTERY DISEASE 5 0.0002
779 MENTAL IMPAIRMENT 4 0.0002
780 CEREBRAL INFARCTION 4 0.0002
781 PAIN IN EXTREMITY 48 0.0002
782 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
783 AGRANULOCYTOSIS 3 0.0002
784 NAUSEA 127 0.0002
785 DRY EYE 8 0.0002
786 LEUKOPENIA 8 0.0002
787 PHOTOPHOBIA 3 0.0002
788 BLOOD SODIUM DECREASED 3 0.0002
789 MUSCLE SPASMS 29 0.0002
790 PRODUCT COMPLAINT 4 0.0002
791 FEELING JITTERY 3 0.0002
792 HEPATITIS 4 0.0002
793 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
794 INFUSION SITE PAIN 2 0.0002
795 SKIN ULCER 4 0.0002
796 LACTIC ACIDOSIS 5 0.0002
797 INJECTION SITE INDURATION 2 0.0002
798 FATIGUE 120 0.0002
799 PLATELET COUNT INCREASED 2 0.0002
800 ALOPECIA 30 0.0002
801 THROMBOCYTOPENIA 17 0.0002
802 STAPHYLOCOCCAL INFECTION 5 0.0002
803 HEADACHE 95 0.0002
804 BLOOD PRESSURE ABNORMAL 3 0.0002
805 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
806 IRRITABILITY 9 0.0001
807 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
808 LIMB INJURY 4 0.0001
809 GINGIVAL BLEEDING 2 0.0001
810 LUNG NEOPLASM MALIGNANT 6 0.0001
811 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
812 MEMORY IMPAIRMENT 20 0.0001
813 HAEMATOCHEZIA 8 0.0001
814 PERITONITIS 3 0.0001
815 PULMONARY HYPERTENSION 3 0.0001
816 NEOPLASM PROGRESSION 5 0.0001
817 PANCYTOPENIA 8 0.0001
818 MASS 2 0.0001
819 HEART RATE DECREASED 5 0.0001
820 BLOOD TEST ABNORMAL 2 0.0001
821 CONSTIPATION 31 0.0001
822 LYMPHADENOPATHY 5 0.0001
823 PAIN IN JAW 4 0.0001
824 PARALYSIS 2 0.0001
825 ANGINA PECTORIS 4 0.0001
826 POOR QUALITY SLEEP 3 0.0001
827 HERPES ZOSTER 8 0.0001
828 MENTAL DISORDER 6 0.0001
829 FLUID RETENTION 7 0.0001
830 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
831 BLOOD PRESSURE INCREASED 21 0.0001
832 PANIC ATTACK 5 0.0001
833 GASTROENTERITIS 2 0.0001
834 DYSSTASIA 4 0.0001
835 PALPITATIONS 16 0.0001
836 CHILLS 16 0.0001
837 COLON CANCER 2 0.0001
838 ECZEMA 7 0.0001
839 FEELING ABNORMAL 32 0.0001
840 INTESTINAL OBSTRUCTION 5 0.0001
841 APHASIA 4 0.0001
842 PANCREATITIS 7 0.0001
843 DEPRESSED MOOD 7 0.0001
844 BLOOD COUNT ABNORMAL 2 0.0001
845 ERYTHEMA 27 0.0001
846 DRUG DEPENDENCE 21 0.0001
847 ARTHRALGIA 54 0.0001
848 LYMPHOMA 2 0.0001
849 RASH PRURITIC 7 0.0001
850 MENINGIOMA 2 0.0001
851 DYSPHAGIA 12 0.0001
852 HEAD INJURY 4 0.0001
853 DISEASE RECURRENCE 6 0.0001
854 DEATH 108 0.0001
855 MOVEMENT DISORDER 4 0.0001
856 CARDIAC FAILURE CONGESTIVE 10 0.0001
857 HYPOGLYCAEMIA 6 0.0001
858 OFF LABEL USE 108 0.0001
859 DEEP VEIN THROMBOSIS 8 0.0001
860 VISUAL ACUITY REDUCED 4 0.0001
861 COAGULOPATHY 2 0.0001
862 FUNGAL INFECTION 4 0.0001
863 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
864 CELLULITIS 6 0.0001
865 CANDIDA INFECTION 2 0.0001
866 HAEMATEMESIS 3 0.0001
867 CARDIOVASCULAR DISORDER 3 0.0001
868 MYALGIA 20 0.0001
869 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
870 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
871 ARTHRITIS 9 0.0001
872 DEPRESSION 26 0.0001
873 ANGIOEDEMA 5 0.0001
874 HEAD DISCOMFORT 2 0.0001
875 BACK PAIN 26 0.0001
876 FEAR 3 0.0001
877 BLOOD BILIRUBIN INCREASED 3 0.0001
878 THROAT TIGHTNESS 3 0.0001
879 INCORRECT DOSE ADMINISTERED 25 0.0001
880 PAIN 67 0.0001
881 DYSURIA 4 0.0001
882 DYSGEUSIA 8 0.0001
883 SWELLING FACE 7 0.0001
884 ARRHYTHMIA 5 0.0001
885 FOOT FRACTURE 2 0.0001
886 RENAL FAILURE 14 0.0001
887 FALL 35 0.0001
888 RED BLOOD CELL COUNT DECREASED 3 0.0001
889 POST PROCEDURAL COMPLICATION 2 0.0001
890 BALANCE DISORDER 9 0.0001
891 WEIGHT DECREASED 29 0.0001
892 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
893 URINARY INCONTINENCE 3 0.0001
894 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
895 PRODUCT PHYSICAL ISSUE 2 0.0001
896 BONE MARROW FAILURE 2 0.0001
897 EPILEPSY 3 0.0001
898 HAEMOGLOBIN DECREASED 10 0.0001
899 ILLNESS 10 0.0001
900 LIMB DISCOMFORT 3 0.0001
901 VISUAL IMPAIRMENT 12 0.0001
902 MOUTH ULCERATION 2 0.0001
903 RENAL FAILURE ACUTE 4 0.0001
904 CYSTITIS 3 0.0001
905 PRURITUS GENERALISED 2 0.0001
906 PRODUCT PRESCRIBING ISSUE 2 0.0001
907 ORAL PAIN 2 0.0001
908 HEART RATE IRREGULAR 2 0.0001
909 FLATULENCE 5 0.0001
910 CHEST DISCOMFORT 9 0.0001
911 PRODUCT AVAILABILITY ISSUE 2 0.0001
912 GASTRIC DISORDER 3 0.0001
913 VISION BLURRED 12 0.0001
914 SKIN DISCOLOURATION 4 0.0001
915 SEIZURE 10 0.0001
916 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
917 DISEASE PROGRESSION 10 0.0001
918 OCULAR HYPERAEMIA 4 0.0001
919 NEUROPATHY PERIPHERAL 8 0.0001
920 CEREBRAL HAEMORRHAGE 3 0.0001
921 BLOOD PRESSURE FLUCTUATION 2 0.0001
922 BLOOD GLUCOSE DECREASED 4 0.0001
923 LOCALISED INFECTION 2 0.0001
924 CRYING 3 0.0001
925 NEURALGIA 2 0.0001
926 DIABETES MELLITUS 6 0.0001
927 HYPOPHAGIA 2 0.0001
928 RASH GENERALISED 2 0.0001
929 DEAFNESS 2 0.0001
930 MUCOSAL INFLAMMATION 2 0.0001
931 SPEECH DISORDER 4 0.0001
932 DYSKINESIA 3 0.0001
933 PALLOR 2 0.0001
934 ABNORMAL DREAMS 2 0.0001
935 HOSPITALISATION 11 0.0001
936 SKIN EXFOLIATION 6 0.0001
937 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
938 EYE PAIN 4 0.0001
939 THERAPY INTERRUPTED 5 0.0001
940 SYNCOPE 7 0.0001
941 BONE PAIN 4 0.0001
942 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
943 ACUTE MYOCARDIAL INFARCTION 2 0.0001
944 CATARACT 4 0.0001
945 HAEMORRHAGE 7 0.0001
946 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
947 NO ADVERSE EVENT 12 0.0001
948 THERAPEUTIC RESPONSE DECREASED 4 0.0001
949 NEPHROLITHIASIS 3 0.0001
950 EMOTIONAL DISORDER 2 0.0001
951 FEMUR FRACTURE 2 0.0001
952 COGNITIVE DISORDER 3 0.0001
953 PULMONARY EMBOLISM 6 0.0001
954 HIP FRACTURE 2 0.0001
955 PSORIASIS 8 0.0001
956 LIP SWELLING 2 0.0001
957 BLOOD GLUCOSE INCREASED 11 0.0001
958 ABDOMINAL DISTENSION 6 0.0001
959 NERVOUSNESS 3 0.0001
960 BURNING SENSATION 4 0.0001
961 PRODUCT DOSE OMISSION ISSUE 16 0.0001
962 EYE SWELLING 2 0.0001
963 NECK PAIN 3 0.0001
964 BREAST CANCER 5 0.0001
965 HOT FLUSH 4 0.0001
966 EYE IRRITATION 3 0.0001
967 ABORTION SPONTANEOUS 2 0.0000
968 EXTRA DOSE ADMINISTERED 2 0.0000
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
970 BLINDNESS 2 0.0000
971 POLLAKIURIA 2 0.0000
972 DRUG WITHDRAWAL SYNDROME 4 0.0000
973 NEOPLASM MALIGNANT 3 0.0000
974 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
975 SUICIDAL IDEATION 4 0.0000
976 RASH ERYTHEMATOUS 2 0.0000
977 MULTIPLE SCLEROSIS 2 0.0000
978 CEREBROVASCULAR ACCIDENT 7 0.0000
979 MYOCARDIAL INFARCTION 7 0.0000
980 NEUTROPENIA 5 0.0000
981 DEPENDENCE 2 0.0000
982 CARDIAC DISORDER 3 0.0000
983 PRODUCT DOSE OMISSION 2 0.0000
984 PRODUCT QUALITY ISSUE 4 0.0000
985 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
986 INJECTION SITE REACTION 2 0.0000
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
988 ACNE 2 0.0000
989 CHRONIC KIDNEY DISEASE 2 0.0000
990 EMOTIONAL DISTRESS 3 0.0000
991 DRUG DOSE OMISSION 4 0.0000
992 DEVICE ISSUE 2 0.0000